Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
News Briefs
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
News Briefs
,
Breast Cancer
,
In the Literature
Web Exclusives
This week Sellas Life Sciences Group announced data from a study of NeuVax (nelipepimut-S) in combination with Herceptin (trastuzumab) in patients with HER2 1+/2+ breast cancer.
Read More ›
RCCA and GenPath Oncology Partnership Will Benefit Nearly a Quarter Million NJ Cancer Patients
News Briefs
August 2013, Vol 3, No 5
Read More ›
Colorado Hospital Earns Joint Commission’s Gold Seal of Approval
News Briefs
August 2013, Vol 3, No 5
Read More ›
Precyse Awarded Prestigious HFMA Designation for HIM Technology
News Briefs
August 2013, Vol 3, No 5
Read More ›
US Preventive Services Task Force Issues Draft Recommendation Statement on Lung Cancer Screening
News Briefs
August 2013, Vol 3, No 5
Read More ›
News Briefs - June 2013
News Briefs
June 2013, Vol 3, No 4
Read More ›